ResearchSafe

CagriSema combo data looks promising, anyone tracking amylin analog stacks yet?

Posted by weekendnate in Weight Loss & Metabolic - 1 points, 2 comments.

Been digging into CagriSema since the dual-mechanism approach caught my attention. The idea of hitting both the amylin pathway and GLP-1 at once seems like it could move the needle more than just titrating sema higher, especially for people who plateau around the 15-18% loss mark. What interests me is the satiety angle from cagrilintide working through the area postrema rather than purely hypothalamic GLP-1 signaling. Sounds like it could help with the food noise that some folks still report even at therapeutic sema doses.

For anyone who has actually run a cagrilintide-containing combo, how did the nausea compare to straight GLP-1 titration? I'm wondering if the side effect profile stacks linearly or if there's some kind of ceiling effect because the pathways are complementary rather than redundant. Also curious whether the appetite suppression felt qualitatively different, like more "fullness" versus just "not hungry."

I know the trial numbers look strong but I want to hear from people actually experimenting before I get too excited about the theoretical ceiling.

Comments

  • runner_aaron: Honestly I've only played around with cagrilintide on its own for a short stretch, so I can't speak to the combo directly. On its own though the nausea was rougher than sema for me, especially the first week, but it did feel different for satiety. More like actual fullness rather than just not wanting food, which I reckon is the amylin piece doing its thing through different receptors. What I want to know is whether running cagrilintide lower than the trial dose keeps the fullness benefit but d
  • weekendnate: Yeah that fullness vs just-not-craving distinction is exactly what stood out to me too, and honestly the main reason I'm interested in stacking it rather than just pushing sema harder. Reasonable question on the lower dose, my guess is you'd keep a decent chunk of the satiety signal since amylin receptor activation tends to have a flatter dose-response than GLP-1, but the nausea would probably still show up in the first couple weeks because that's more of an acute area postrema thing. Did your s

Community discussion - research and educational context only. Not medical advice.